Dennis P. Reilly
Net Worth

Last updated:

What is Dennis P. Reilly net worth?

The estimated net worth of Mr. Dennis P. Reilly is at least $2,753,800 as of 13 Oct 2021. He has received compensation worth at least $2,753,800 in Agile Therapeutics, Inc..

What is the salary of Dennis P. Reilly?

Mr. Dennis P. Reilly salary is $550,760 per year as Senior Vice President & Chief Financial Officer in Agile Therapeutics, Inc..

How old is Dennis P. Reilly?

Mr. Dennis P. Reilly is 66 years old, born in 1959.

What stocks does Dennis P. Reilly currently own?

As insider, Mr. Dennis P. Reilly owns shares in one company:

Company Title Shares Price per share Total value
Agile Therapeutics, Inc. (AGRX) Senior Vice President & Chief Financial Officer 29,412 $0 $0

What does Agile Therapeutics, Inc. do?

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.

AGRX logo
AGRX
Agile Therapeutics, Inc.

Dennis P. Reilly insider trading

Agile Therapeutics, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 58,824 N/A N/A
Purchase
Warrants (right to buy) 29,412 $0.85 $25,000
Purchase
Common Stock 50,000 $1.08 $54,150
Purchase
Common Stock 20,000 $1.35 $27,000
Purchase
Common Stock 50,000 N/A N/A
Purchase
Common Stock 9,000 $2.85 $25,650
Option
Employee Stock Option (Right to Buy) 37,500 N/A N/A
Purchase
Common Stock 75,000 $1.18 $88,125

Agile Therapeutics key executives

Agile Therapeutics, Inc. executives and other stock owners filed with the SEC: